Welcome to our dedicated page for ENSIGN GROUP SEC filings (Ticker: ENSG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Ensign Group, Inc. (ENSG) filings document its public-company reporting as a Delaware healthcare services company with common stock listed on the Nasdaq Global Select Market. Its disclosures cover skilled nursing and senior living operations, therapy and rehabilitative services, healthcare real estate, and the Standard Bearer real estate segment.
Ensign’s 8-K reports disclose quarterly and annual operating results and Regulation G non-GAAP measures, including adjusted net income, adjusted earnings per share, EBITDA, adjusted EBITDA, adjusted EBITDAR, adjusted EBT, and Funds from Operations for its real estate segment. Proxy materials cover shareholder voting, board governance, executive compensation, equity awards, capital-structure matters, and other governance disclosures.
Form 144 filed for Ensign Group, Inc. (ENSG) reports a proposed sale of 700 common shares through Fidelity Brokerage Services with an aggregate market value of $120,400, approximately 700 of the company's 57,700,157 outstanding shares, with an approximate sale date of 10/01/2025 on NASDAQ. The filing lists prior sales by the same person on 07/01/2025, 08/01/2025, and 09/02/2025, each of 700 shares with gross proceeds shown. Acquisition details show the shares were received as restricted stock vesting on 01/15/2022 and 01/18/2023 as compensation.
Uychiat Pison Marivic filed an Initial Statement of Beneficial Ownership for The Ensign Group, Inc. (ENSG) reporting direct ownership of 12,963 common shares and multiple employee stock options and restricted stock awards. Reported derivative holdings include options exercisable from 08/26/2020 through 11/06/2025 covering 17,559 shares in aggregate under various exercise prices, and unvested RSAs totaling 2,040 shares subject to five-year vesting schedules.
Chad A. Keetch, CIO, EVP and Secretary of The Ensign Group, Inc. (ENSG), reported a gift disposition of 2,820 shares of Ensign common stock on 09/05/2025. The transaction is coded as a G (gift) at $0. After the reported transaction, Mr. Keetch beneficially owns 94,800 shares directly. No derivative transactions were reported. The Form 4 was signed on 09/09/2025.
The Ensign Group director Barry M. Smith reported insider dispositions on 09/02/2025. The filing shows a sale of 700 shares at $172.06 per share and a separate 1,200-share transaction coded G (a gift), leaving the reporting person with 25,852 shares beneficially owned after these transactions. The filing states the sale was executed under a Rule 10b5-1 trading plan adopted on July 31, 2024. The Form 4 was signed by a power of attorney on behalf of the reporting person on 09/04/2025. This document records routine insider activity rather than operational or financial results.
The filer submitted a Form 144 notice for the sale of 700 shares of Common stock via Fidelity Brokerage Services, with an aggregate market value of $120,442 and an approximate sale date of 09/02/2025 on NASDAQ. The shares were acquired through restricted stock vesting on 01/15/2022 (424 shares) and 04/18/2024 (276 shares) and were paid as compensation. The filing lists three prior sales by Barry Smith in the past three months: 700 shares on 06/02/2025 for $102,557, 700 shares on 07/01/2025 for $107,436, and 700 shares on 08/01/2025 for $105,000. The notice includes the standard signature representation that the seller is not aware of undisclosed material adverse information.
The Ensign Group, Inc. reported compensation actions related to the previously announced retirement of director Christopher Christensen from its Board effective September 1, 2025. The compensation committee approved the accelerated vesting, as of August 21, 2025, of 3,300 unvested restricted stock awards and 21,750 unvested stock options in the company, plus 1,000 unvested restricted stock awards in Standard Bearer Healthcare REIT, Inc.
Mr. Christensen will receive a cash bonus of $2,070,000 for services from January 1, 2025 to September 1, 2025, and a cash subsidy of up to $150,000 as prepayment for five years of health insurance premiums starting September 1, 2025. He may provide advisory services to management for up to one year at a rate not exceeding $100,000 per year. Under the Standard Bearer 2022 Omnibus Incentive Plan, the company will repurchase 19,726 Standard Bearer common shares and one preferred share from Mr. Christensen for a total of $287,393, based on third-party fair market value.
The Ensign Group director Daren Shaw reported a sale of 1,000 shares of ENSG common stock on 08/15/2025 at a price of $166.17 per share. After the reported sale Mr. Shaw beneficially owned 24,526 shares directly. The filing discloses the sale was effected under a Rule 10b5-1 trading plan adopted May 7, 2025, indicating the transaction followed a pre-established written plan. The Form 4 was signed by a power of attorney on 08/19/2025.
The Ensign Group, Inc. (ENSG) Form 144 notice reports a proposed sale of 1,000 common shares through Fidelity Brokerage Services with an aggregate market value of $166,170.00, scheduled approximately 08/15/2025 on NASDAQ. The shares were acquired via restricted stock vesting on various dates (2018 and 2025) and paid as compensation. The filer disclosed prior sales of 1,999 shares on 05/15/2025 generating $290,794.53. The notice includes the required attestation about material nonpublic information.
The Ensign Group, Inc. insider disclosed an option exercise and immediate sale by CEO and director Barry Port. The reporting person exercised 2,399 employee stock options with a $15.93 exercise price and sold 2,399 shares at $160 per share on 08/08/2025 under a Rule 10b5-1 trading plan adopted May 6, 2024.
The report shows the reporting persons direct beneficial ownership after the transactions as 57,030 shares and indirect beneficial ownership of 155,300 shares held of record by trusts for Barry R. Port and spouse Michelle Port. The underlying options were granted August 31, 2016 and vested over five equal annual installments.
The filing is a Form 144 for The Ensign Group, Inc. (ENSG) disclosing a proposed sale of 2,399 common shares. The seller intends to execute the transaction through Fidelity Brokerage Services LLC on or about 08/08/2025. Based on the filing, the shares carry an aggregate market value of $383,840, while the company has 57,700,157 shares outstanding. The securities were originally obtained via an employee stock option granted on 08/31/2016 and will be purchased for cash at exercise on the transaction date. No other sales by this individual occurred within the last three months. The notice affirms that the filer possesses no undisclosed material adverse information about the issuer.